Gilead Sciences Inc is developing easier-to-administer versions of its antiviral treatment remdesivir for COVID-19 that could be used outside of ...
FOSTER CITY, California: Gilead Sciences Inc is developing easier-to-administer versions of its antiviral treatment remdesivir for COVID-19 that could be used outside of hospitals, including ones that can be inhaled, after trials showed moderate effectiveness for the drug given by infusion.
Gilead in a statement on Monday said it is looking at ways to use remdesivir earlier in the course of disease, including via alternate formulations. The company confirmed in an email that it is researching an inhaled version, but declined further comment.Company executives such as Chief Medical Officer Merdad Parsey and Chief Financial Officer Andrew Dickinson have been doing interviews with Wall Street analysts in recent weeks to discuss the plans, which are in early stages.
The idea is that a nebuliser would make remdesivir more directly available to upper airway and lung tissue as the coronavirus is known to attack the lungs. It would also allow for early treatment of coronavirus patients who are not hospitalised.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Gilead's antiviral drug remdesivir results mixed in moderate COVID-19 patientsFOSTER CITY, California: Gilead Sciences said on Monday (Jun 6) its antiviral drug remdesivir had mixed results in a late stage study of people ...
Read more »
Gilead's remdesivir results mixed in patients with moderate Covid-19WASHINGTON (REUTERS) - Gilead Sciences said on Monday (June 1) its antiviral drug remdesivir had mixed results in a late stage study of people with moderate Covid-19, as patients given a five-day course of the treatment showed statistically significant improvement, while those given it for 10 days did not.. Read more at straitstimes.com.
Read more »
Gilead's remdesivir shows modest improvement in moderate COVID-19 patientsFOSTER CITY, California: Gilead Sciences Inc on Monday (Jun 1) reported that its antiviral drug remdesivir provided a modest benefit in patients ...
Read more »
India approves emergency use of remdesivir to treat COVID-19 patientsIndia's government said on Tuesday it has approved Gilead Sciences Inc's antiviral drug remdesivir for emergency use in treating COVID-19 patients.
Read more »
Britain takes its biggest step yet out of coronavirus lockdownLONDON (AFP) - Younger children went back to schools in England on Monday (June 1) and Parliament geared up to resume normal service, as the world's second-worst-hit country in the coronavirus outbreak took its biggest step yet out of a lockdown that police warned was becoming difficult to enforce.. Read more at straitstimes.com.
Read more »
New Zealand may remove most coronavirus restrictions next weekWELLINGTON (BLOOMBERG) - New Zealand could remove most of its remaining restrictions on people and businesses as soon as next week after successfully wiping out the coronavirus.. Read more at straitstimes.com.
Read more »